JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
REVIEW
Add like
Add dislike
Add to saved papers

Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis.

The characterization of corticotropin-releasing factor (CRF) and CRF receptors and the use of specific CRF antagonists have paved the way to establish a key role of brain CRF in the coding of the stress response. CRF injected into the cerebrospinal fluid or the periphery inhibits gastric emptying in various species. The paraventricular nucleus of the hypothalamus and dorsal vagal complex are brain sites of action for CRF. Endogenous brain CRF plays a role in mediating psychological, physical, somatovisceral, and immunological stress-induced delayed gastric emptying in rats. Postoperative gastric ileus is also prevented by peripheral injection of CRF antagonists. Cyclic vomiting syndrome (CVS) is precipitated by stimuli or states associated with stimulation of CRF release, and the resulting endocrine, autonomic, and visceral changes are indicative of central CRF activation. Moreover, empiric pharmacotherapy alleviating CVS symptoms are known experimentally to block CRF release or action. The relevance of central CRF activation in the pathophysiology of CVS deserves further consideration.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app